William Blair Downgrades Neumora Therapeutics (NMRA) to Market Perform

March 10, 2025 4:43 AM EDT Send to a Friend
(Updated - March 10, 2025 7:24 AM EDT)

William Blair analyst Myles R. Minter downgraded Neumora Therapeutics (NASDAQ: NMRA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login